Dedication to Medical Excellence

RMANY Difference

Our dedication to medical excellence is exemplified through extensive training and education provided to our staff who in turn partner with patients to achieve positive reproductive outcomes. The RMA of New York team combines personalized and patient-centered care with cutting-edge technologies including embryo biopsy and screening via preimplantation genetic testing (PGT) next-generation sequencing followed by elective single embryo transfer (eSET) to reduce the risk of chromosomal abnormalities, miscarriages, and multiple gestations.

For the first several decades of in vitro fertilization, it was common to retrieve, fertilize and then transfer the best embryo or embryos into the uterus. The problem with performing a fresh embryo transfer is that the endometrium is often advanced and the chance of a successful implantation could be compromised.

“The reproductive journey is different now than it was 20 years ago, 10 years ago, and will be months from now. By analyzing big data, accessing machine learning algorithms and artificial intelligence, focusing on genomic and personalized medicine, and ultimately relying on compassionate and consistent clinical care, physicians can improve reproductive outcomes for their patients. We are proud to contribute to science, and look forward to participating in the advancement of the field of reproductive medicine for years to come.”
Alan B. Copperman, MD

Now that we are routinely genetically screening embryos prior to transfer and have data to support our medical decisions, it is clear that transferring an embryo into a prepared endometrium gives it a much greater chance of surviving and becoming a healthy ongoing pregnancy. Freezing and thawing technologies have significantly improved, and as a result, we are experiencing a 98% embryo survival rate with vitrification and rewarming. The additional several weeks added to an IVF cycle by implementing modern IVF technologies including biopsy, freezing, and thawing is a minimal cost when weighed against higher success rates, lower miscarriage rates, and healthier babies.

What is the RMA of New York Difference?

RMA of New York offers patients personalized, compassionate, and premium quality care. As the Division of Reproductive Endocrinology and Infertility of Mount Sinai Hospital, our team is dedicated to scientific discovery, graduate medical education, and patient-focused care. We are proud to be a member of the Department of Obstetrics, Gynecology, and Reproductive Science at the Icahn School of Medicine at Mount Sinai and of recognition as a Center of Excellence by US News & World Report.

Our physicians, nurses, and care teams provide personalized care to each and every individual. We specialize in meticulous attention to providing personalized, patient-focused care and are culturally and religiously sensitive to meet the needs of individuals and couples visiting from across the globe. Our multi-lingual staff has assisted patients from over 150 countries to date in the most cost-effective and time-efficient manner.

Our established peer-recognized team consistently provides technical and clinical innovation to ensure our patients can benefit from the very latest procedures in the field of fertility.

Advantages of using frozen vs. fresh embryo transfer include:

  • Increased live birth rates
  • Increased implantation rates
  • Increased ongoing pregnancy rates
  • Decreased miscarriage rates
  • Smaller risk of pre-term labor
  • Healthier babies

Our physicians and embryology teams use advanced technology to increase implantation rates, reduce miscarriage rates and increase live birth rates, as evidenced by our success rates well above the national average.

The First Step Towards Your Future

Every journey begins with a first step. Attend a free seminar, speak with
a patient concierge, or schedule a consultation.

Get Started

Sep 27th - In the Know About Endo. Sep 27th - In the Know About Endo. Learn More